celsion,thermodox,doxorubicin,encapsulated doxorubicin,biopharmaceutical,liposome,technology,hepatocellular cancer,cancer therapeutics,chemotherapeutics,heatactivated liposomal technology,oncology,solid cancer lesions,anti-cancer agents,liver cancer,recurrent breast cancer,chest wall cancer,breast cancer,cancer trial,national institutes of health,duke university medical center,university of hong kong,cleveland clinic,north shore long island jewish health system